Using shock wave therapy to treat pain in patients with lower cross syndrome
Effect of Extracorporeal Shock Wave on Electrophysiological Changes and Pain in Patients With Lower Cross Syndrome
This study is testing if combining shock wave therapy with physical therapy can help reduce pain in people with lower cross syndrome.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 44 (estimated) |
| Ages | 30 Years to 45 Years |
| Sex | All |
| Sponsor | AlRyada University for Science & Technology Academic / other |
| Locations | 1 site (Sadat, Menoufia) |
| Trial ID | NCT06531746 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of extracorporeal shock wave therapy combined with a physical therapy program on patients suffering from lower cross syndrome, a condition characterized by muscular imbalances. A total of 44 patients aged 30-45 will be divided into two groups: one receiving shock wave therapy along with physical therapy, and the other receiving only physical therapy. Each participant will undergo 12 treatment sessions over a period of time, with sessions occurring every other day. The goal is to assess changes in pain levels and electrophysiological responses in the affected muscles.
Who should consider this trial
Good fit: Ideal candidates are ambulant individuals aged 30-45 with a body mass index between 20 and 25 who are diagnosed with lower cross syndrome.
Not a fit: Patients with musculoskeletal deformities, psychiatric disorders, or other neuromuscular conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce pain and improve muscle function in patients with lower cross syndrome.
How similar studies have performed: While the specific combination of shock wave therapy and physical therapy for lower cross syndrome is novel, similar approaches have shown promise in treating other musculoskeletal conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Forty-four lower cross syndrome patients from both genders their ages ranged from 30-45 years old. 2. All patients in present study will be ambulant independently. 3. All patients will be medically stable. 4. The body mass index (BMI) will be ranged from 20:25 Kg/m2. Exclusion Criteria: 1. Patients with musculoskeletal deformities and disorders. 2. Patients with psychiatric disorders or seizures. 3. Patients with visual and auditory impairment or tremors influencing balance. 4. Patients with other neuromuscular disorders. 5. Patients with BMI more than 25 kg/m2. 6. Patients with cognitive impairment. 7. Patients with lower limb or head and brain surgeries.
Where this trial is running
Sadat, Menoufia
- Al Ryada University for Science and Technology — Sadat, Menoufia, Egypt (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.